Yuan, J., Maitra, S., Antoniou, E., Zhu, J., Li, W., Demirel, I. S., Toskas, K., Martinez, I. L., Ozcimen, L., Lindehell, H., Muhr, J., Stenman, J., Kogner, P., Bedoya-Reina, O. C., Schlisio, S., Holmberg, J. (2025). HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2516922122